$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000109714915000026 Filed on October 29, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$230.3M	$207.6M	$189.9M
YoY Change	15.96%	9.35%	15.42%
Cost Of Revenue	$57.50M	$50.06M	$44.82M
YoY Change	20.04%	11.69%	13.72%
Gross Profit	$172.8M	$157.6M	$145.1M
YoY Change	14.66%	8.63%	15.96%
Gross Profit Margin	75.03%	75.89%	76.39%
Selling, General & Admin	$99.60M	$101.8M	$108.9M
YoY Change	15.95%	-6.6%	49.82%
% of Gross Profit	57.64%	64.57%	75.1%
Research & Development	$13.90M	$17.78M	$12.85M
YoY Change	4.51%	38.31%	17.76%
% of Gross Profit	8.04%	11.28%	8.86%
Depreciation & Amortization	$4.900M	$4.500M	$4.400M
YoY Change	11.36%	2.27%	-20.0%
% of Gross Profit	2.84%	2.86%	3.03%
Operating Expenses	$113.4M	$119.5M	$93.51M
YoY Change	14.31%	27.83%	11.82%
Operating Profit	$59.40M	$38.05M	$51.55M
YoY Change	15.34%	-26.19%	24.32%
Interest Expense	$300.0K	-$1.600M	-$2.000M
YoY Change	-117.65%	-20.0%	-600.0%
% of Operating Profit	0.51%	-4.21%	-3.88%
Other Income/Expense, Net		-$1.568M	-$1.999M
YoY Change		-21.56%	-545.21%
Pretax Income	$59.70M	$36.48M	$49.55M
YoY Change	19.88%	-26.38%	18.22%
Income Tax	$10.80M	$8.862M	$11.30M
% Of Pretax Income	18.09%	24.29%	22.81%
Net Earnings	$48.90M	$27.62M	$38.25M
YoY Change	23.8%	-27.8%	10.74%
Net Earnings / Revenue	21.23%	13.3%	20.14%
Basic Earnings Per Share		$0.35	$0.47
Diluted Earnings Per Share	$600.7K	$0.34	$0.47
COMMON SHARES
Basic Shares Outstanding	79.49M shares	79.81M shares	80.63M shares
Diluted Shares Outstanding		81.09M shares	82.01M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$527.3M	$484.8M	$425.5M
YoY Change	15.98%	13.93%	31.5%
Cash & Equivalents	$167.7M	$174.0M	$180.7M
Short-Term Investments	$359.6M	$310.7M	$244.8M
Other Short-Term Assets	$26.70M	$59.70M	$44.10M
YoY Change	-53.08%	35.37%	26.72%
Inventory	$19.47M	$18.94M	$15.98M
Prepaid Expenses
Receivables	$158.6M	$148.4M	$130.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$732.0M	$711.7M	$615.7M
YoY Change	11.39%	15.6%	27.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$136.5M	$120.7M	$86.45M
YoY Change	51.43%	39.67%	12.93%
Goodwill	$61.07M	$79.72M	$82.93M
YoY Change	-0.48%	-3.87%	34.3%
Intangibles
YoY Change
Long-Term Investments	$0.00	$145.2M	$136.0M
YoY Change	-100.0%	6.76%	77.08%
Other Assets	$8.202M	$7.588M	$7.513M
YoY Change	7.01%	1.0%	-12.94%
Total Long-Term Assets	$426.6M	$367.8M	$332.6M
YoY Change	28.95%	10.59%	20.1%
TOTAL ASSETS
Total Short-Term Assets	$732.0M	$711.7M	$615.7M
Total Long-Term Assets	$426.6M	$367.8M	$332.6M
Total Assets	$1.159B	$1.080B	$948.3M
YoY Change	17.27%	13.84%	24.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.35M	$32.60M	$24.52M
YoY Change	47.78%	32.96%	27.98%
Accrued Expenses	$107.8M	$95.91M	$86.60M
YoY Change	22.63%	10.76%	17.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$271.7M	$244.5M	$198.6M
YoY Change	34.62%	23.14%	21.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.523M	$1.876M	$27.27M
YoY Change	-48.06%	-93.12%	34.65%
Total Long-Term Liabilities	$1.523M	$1.876M	$27.27M
YoY Change	-48.06%	-93.12%	34.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$271.7M	$244.5M	$198.6M
Total Long-Term Liabilities	$1.523M	$1.876M	$27.27M
Total Liabilities	$310.7M	$281.3M	$225.8M
YoY Change	32.09%	24.56%	23.06%
SHAREHOLDERS EQUITY
Retained Earnings	$27.39M	-$11.89M	-$53.14M
YoY Change	-189.79%	-77.62%	-61.59%
Common Stock	$8.000K	$8.000K	$8.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$847.9M	$798.3M	$722.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.159B	$1.080B	$948.3M
YoY Change	17.27%	13.84%	24.91%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$48.90M	$27.62M	$38.25M
YoY Change	23.8%	-27.8%	10.74%
Depreciation, Depletion And Amortization	$4.900M	$4.500M	$4.400M
YoY Change	11.36%	2.27%	-20.0%
Cash From Operating Activities	$79.40M	$60.00M	$67.60M
YoY Change	10.89%	-11.24%	22.46%
INVESTING ACTIVITIES
Capital Expenditures	-$16.80M	-$10.50M	-$7.000M
YoY Change	136.62%	50.0%	20.69%
Acquisitions
YoY Change
Other Investing Activities	-$56.90M	-$21.80M	-$46.80M
YoY Change	146.32%	-53.42%	-7.14%
Cash From Investing Activities	-$73.80M	-$32.30M	-$53.80M
YoY Change	144.37%	-39.96%	-4.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.80M	-14.10M	-1.000M
YoY Change	-39.49%	1310.0%	-107.69%
NET CHANGE
Cash From Operating Activities	79.40M	60.00M	67.60M
Cash From Investing Activities	-73.80M	-32.30M	-53.80M
Cash From Financing Activities	-11.80M	-14.10M	-1.000M
Net Change In Cash	-6.200M	13.60M	12.80M
YoY Change	-128.31%	6.25%	6.67%
FREE CASH FLOW
Cash From Operating Activities	$79.40M	$60.00M	$67.60M
Capital Expenditures	-$16.80M	-$10.50M	-$7.000M
Free Cash Flow	$96.20M	$70.50M	$74.60M
YoY Change	22.24%	-5.5%	22.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	algn	Accelerated Share Repurchase Contracted Amountof Repurchase AcceleratedShareRepurchaseContractedAmountofRepurchase	70000000	USD
CY2015Q2	algn	Accelerated Share Repurchase Contracted Amountof Repurchase AcceleratedShareRepurchaseContractedAmountofRepurchase	70000000	USD
CY2014Q4	algn	Accrued Accounts Payable AccruedAccountsPayable	5736000	USD
CY2015Q3	algn	Accrued Accounts Payable AccruedAccountsPayable	8582000	USD
CY2014Q4	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	5979000	USD
CY2015Q3	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	6006000	USD
CY2014Q4	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1563000	USD
CY2015Q3	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1803000	USD
CY2014Q3	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.09
	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.28
CY2015Q3	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.10
	algn	Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare	0.30
CY2014Q4	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	13540000	USD
CY2015Q3	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	15490000	USD
CY2014Q4	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2015Q3	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2015Q3	algn	Future Amortization Expense Thereafter FutureAmortizationExpenseThereafter	7695000	USD
CY2014	algn	Maturity Period Used To Classify Investments MaturityPeriodUsedToClassifyInvestments	P11M
	algn	Maturity Period Used To Classify Investments MaturityPeriodUsedToClassifyInvestments	P10M
CY2015Q3	algn	Operating Leases Future Minimum Payments Due Remainder Of Period OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod	2594000	USD
	algn	Standard Product Warranty Time Period StandardProductWarrantyTimePeriod	P1Y
CY2014Q2	algn	Stock Repurchase Program Authorized Amountfor Next Twelve Months StockRepurchaseProgramAuthorizedAmountforNextTwelveMonths	100000000	USD
CY2014	algn	Stock Repurchased During Period Average Price Per Share StockRepurchasedDuringPeriodAveragePricePerShare	50.93
CY2015Q1	algn	Stock Repurchased During Period Average Price Per Share StockRepurchasedDuringPeriodAveragePricePerShare	57.49
CY2015Q3	algn	Stock Repurchased During Period Average Price Per Share StockRepurchasedDuringPeriodAveragePricePerShare	57.04
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001097149
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79490148	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ALIGN TECHNOLOGY INC
	dei	Trading Symbol TradingSymbol	ALGN
CY2015Q2	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	-70000000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23247000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	32599000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	129751000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	148395000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2027000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2400000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	87880000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	95914000	USD
CY2014Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	11110000	USD
CY2015Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	7172000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2494000	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3841000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-140000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	783410000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810116000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9910000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29348000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14661000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39135000	USD
CY2014Q4	us-gaap	Assets Assets	987997000	USD
CY2015Q3	us-gaap	Assets Assets	1079562000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	657160000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	711733000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	402679000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	455961000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	254787000	USD
CY2015Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	310715000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	254787000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	310715000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	147892000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	145246000	USD
CY2014Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	147892000	USD
CY2015Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	145246000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242953000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180676000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199871000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	174040000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-62277000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-25831000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80205000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79564000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80205000	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79564000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	37799000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	106055000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27828000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	95308000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	44822000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	135272000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	50060000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	147910000	USD
CY2013Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0175
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20870000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4017000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	90684000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	115998000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	37053000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	30090000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3099000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	14542000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13469000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13141000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	720000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2893000	USD
CY2014Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.248
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44610000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48150000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	18887000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	8663000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	18887000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	8663000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	650000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2592000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2600000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2600000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53485000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53485000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20687000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18737000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	82056000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	79715000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	145054000	USD
	us-gaap	Gross Profit GrossProfit	427781000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	157576000	USD
	us-gaap	Gross Profit GrossProfit	467300000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	49548000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	140592000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36478000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	126449000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11301000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34301000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8862000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31306000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	7700000	USD
	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	22800000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3788000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4408000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24930000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27123000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	12402000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6712000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	9957000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28182000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2033000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3033000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2349000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2529000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4815000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2590000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	15928000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	18939000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8143000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9690000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2970000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6659000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	235226000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	281303000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	987997000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1079562000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	201811000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	244511000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-46918000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-88955000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-171373000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92625000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155294000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	158642000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	38247000	USD
	us-gaap	Net Income Loss NetIncomeLoss	106291000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	27616000	USD
	us-gaap	Net Income Loss NetIncomeLoss	95143000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	90125000	USD
CY2015Q3	us-gaap	Noncurrent Assets NoncurrentAssets	120738000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1999000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1491000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1568000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2846000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	93507000	USD
	us-gaap	Operating Expenses OperatingExpenses	285698000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	119530000	USD
	us-gaap	Operating Expenses OperatingExpenses	338005000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	51547000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	142083000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	38046000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	129295000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	21904000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	529000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2409000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5952000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	9982000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	438000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7320000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11402000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7665000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7588000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-191000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-81000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	98000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	260000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-257000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-155000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	114000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-95000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-448000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-236000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	212000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	165000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2932000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1876000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7368000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9252000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	182000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-46000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	77417000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	90603000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5761000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17574000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	350611000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	306938000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16957000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36663000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19770000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29554000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17373000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10559000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	124101000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	238412000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	72276000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	12518000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90125000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120738000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12854000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39523000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17779000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47348000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30507000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11890000	USD
CY2014Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5456000	USD
CY2015Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5650000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	189876000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	563053000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	207636000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	615210000	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	80653000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	246175000	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	101751000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	290657000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	29348000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	39135000	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.358
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.388
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.279
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.311
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.002
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0020
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0041
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0029
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	539000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.44
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.15
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.19
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22300000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	668000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	539000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.57
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.36
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	22300000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	539000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	15.36
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.47
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	22300000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y3M11D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M11D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y3M11D
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3104000	USD
CY2014Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3263000	USD
CY2014Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3148000	USD
CY2015Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2711000	USD
CY2014Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	3148000	USD
CY2015Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	2711000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1370000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1745000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1529000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1308000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	129000	shares
CY2014Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	USD
CY2015Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	USD
CY2014Q2	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2014	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	600000	shares
CY2015Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	30000	shares
CY2015Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	28200000	USD
CY2015Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1800000	USD
CY2015Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18800000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	752771000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	798259000	USD
CY2014Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	30483000	USD
CY2015Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	34916000	USD
CY2015Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	800000	shares
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	33100000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	37800000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1385000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1519000	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1284000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1403000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82014000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82443000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81092000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81576000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80629000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80924000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79808000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80173000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-align:justify;text-indent:16px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") in the United States of America (“U.S.”) requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, useful lives of intangible assets and property and equipment, revenue recognition, stock-based compensation, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>

Files In Submission

Name	View Source	Status
0001097149-15-000026-index-headers.html	Edgar Link	pending
0001097149-15-000026-index.html	Edgar Link	pending
0001097149-15-000026.txt	Edgar Link	pending
0001097149-15-000026-xbrl.zip	Edgar Link	pending
algn-20150930.htm	Edgar Link	pending
algn-20150930.xml	Edgar Link	completed
algn-20150930.xsd	Edgar Link	pending
algn-20150930_cal.xml	Edgar Link	unprocessable
algn-20150930_def.xml	Edgar Link	unprocessable
algn-20150930_lab.xml	Edgar Link	unprocessable
algn-20150930_pre.xml	Edgar Link	unprocessable
algn-2015930xex311.htm	Edgar Link	pending
algn-2015930xex312.htm	Edgar Link	pending
algn-2015930xex321.htm	Edgar Link	pending
algn201503chartx40449a01a01.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2015 Q4 Form 10-Q Financial Statement

#000109714915000026 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2015 Q4 Form 10-Q Financial Statement

#000109714915000026 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn